Amiodarone is more efficient than verapamil in reversing resistance to anthracyclines in tumour cells.

Por Chauffert, B., Rey, D., Coudert, B., Dumas, M., Martin, F.
Publicado em 1987

Potential usefulness of quinine to circumvent the anthracycline resistance in clinical practice.

Por Chauffert, B., Pelletier, H., Corda, C., Solary, E., Bedenne, L., Caillot, D., Martin, F.
Publicado em 1990

The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models

Por Colin, D J, Limagne, E, Ragot, K, Lizard, G, Ghiringhelli, F, Solary, É, Chauffert, B, Latruffe, N, Delmas, D
Publicado no Cell Death Dis (2014)

Deleterious effect of serum proteins on the amphotericin B-induced potentiation of cisplatin in human colon cancer cells.

Por Assem, M., Bonvalot, S., Beltramo, J. L., Garrido, C., Dimanche-Boitrel, M. T., Genne, P., Rebibou, J. M., Caillot, D., Chauffert, B.
Publicado em 1994

Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level

Por Morizot, A, Mérino, D, Lalaoui, N, Jacquemin, G, Granci, V, Iessi, E, Lanneau, D, Bouyer, F, Solary, E, Chauffert, B, Saas, P, Garrido, C, Micheau, O
Publicado em 2011

Increase of CD4(+)CD25(+) regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eli...

Por Audia, S, Nicolas, A, Cathelin, D, Larmonier, N, Ferrand, C, Foucher, P, Fanton, A, Bergoin, E, Maynadie, M, Arnould, L, Bateman, A, Lorcerie, B, Solary, E, Chauffert, B, Bonnotte, B
Publicado em 2007

Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[(18)F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002)

Por Bourguet, P, Blanc-Vincent, M P, Boneu, A, Bosquet, L, Chauffert, B, Corone, C, Courbon, F, Devillers, A, Foehrenbach, H, Lumbroso, J D, Mazselin, P, Montravers, F, Moretti, J L, Talbot, J N
Publicado em 2003

Intraperitoneal clearance as a potential biomarker of cisplatin after intraperitoneal perioperative chemotherapy: a population pharmacokinetic study

Por Royer, B, Kalbacher, E, Onteniente, S, Jullien, V, Montange, D, Piedoux, S, Thiery-Vuillemin, A, Delroeux, D, Pili-Floury, S, Guardiola, E, Combe, M, Muret, P, Nerich, V, Heyd, B, Chauffert, B, Kantelip, J-P, Pivot, X
Publicado em 2012